Swedbank Ab Alnylam Pharmaceuticals, Inc. Transaction History

Swedbank Ab

$77.1 Billion
Q3 2024

A detailed history of Swedbank Ab transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Swedbank Ab holds 53,729 shares of ALNY stock, worth $13.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

53,729

Previous 20,639 160.33%

Holding current value

$13.2 Million

Previous $5.02 Million 194.7%

% of portfolio

0.02%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$233.81 - $287.01 $7.74 Million - $9.5 Million	33,090 Added 160.33%	53,729 $14.8 Million
Q1 2024 May 21, 2024	BUY	$146.51 - $198.2 $3.02 Million - $4.09 Million	20,639 New	20,639 $3.08 Billion
Q3 2023 Dec 09, 2024	SELL	$170.77 - $211.65 $19.3 Million - $24 Million	-113,303 Reduced 33.93%	220,639 $39.1 Million
Q1 2023 Dec 09, 2024	SELL	$182.66 - $235.53 $16.9 Million - $21.8 Million	-92,711 Reduced 21.73%	333,942 $66.9 Million
Q4 2022 Dec 09, 2024	BUY	$185.53 - $241.31 $1.97 Million - $2.56 Million	10,593 Added 2.55%	426,653 $101 Million
Q3 2022 Dec 09, 2024	SELL	$138.54 - $232.0 $3.21 Million - $5.37 Million	-23,152 Reduced 5.27%	416,060 $83.3 Million
Q2 2022 Dec 09, 2024	BUY	$120.42 - $169.29 $103,079 - $144,912	856 Added 0.2%	439,212 $64.1 Million
Q1 2022 Dec 09, 2024	BUY	$127.18 - $173.91 $227,779 - $311,472	1,791 Added 0.41%	438,356 $71.6 Million
Q4 2021 Dec 09, 2024	BUY	$159.56 - $209.29 $10,690 - $14,022	67 Added 0.02%	436,565 $74 Million
Q3 2021 Dec 09, 2024	BUY	$169.75 - $207.73 $15.4 Million - $18.9 Million	90,986 Added 26.33%	436,498 $82.4 Million
Q2 2021 Dec 09, 2024	BUY	$128.63 - $176.89 $667,975 - $918,589	5,193 Added 1.53%	345,512 $58.6 Million
Q1 2021 Dec 09, 2024	BUY	$126.83 - $175.69 $43.2 Million - $59.8 Million	340,319 New	340,319 $48 Million

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

News

Stay updated on Swedbank Ab with notifications on news.

Account